Found: 7
Select item for more details and to access through your institution.
Phase I study of an oral formulation of irinotecan administered daily for 14 days every 3 weeks in patients with advanced solid tumours.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycin.
- Published in:
- 1984
- By:
- Publication type:
- journal article
Urinary and fecal excretion of topotecan in patients with malignant solid tumours.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 1, p. 59, doi. 10.1007/s00280-002-0454-2
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 49, n. 3, p. 201, doi. 10.1007/s002800100371
- By:
- Publication type:
- Article
A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2001, v. 47, n. 4, p. 347, doi. 10.1007/s002800000226
- By:
- Publication type:
- Article
Multicenter Phase II Study of Spiroplatin.
- Published in:
- Oncology, 1992, v. 49, n. 2, p. 99, doi. 10.1159/000227020
- By:
- Publication type:
- Article
CA 125: A valid marker in ovarian carcinoma patients treated with paclitaxel?
- Published in:
- Cancer (0008543X), 1996, v. 78, n. 1, p. 118, doi. 10.1002/(SICI)1097-0142(19960701)78:1<118::AID-CNCR17>3.0.CO;2-2
- By:
- Publication type:
- Article